论文部分内容阅读
目的：研究超早期小骨窗微创脑出血清除术治疗高血压脑出血的应用效果。方法：选择2013年4月至2015年4月在我院治疗高血压脑出血患者157例患者作为研究对象，分为三组，A组57例患者实施超早期小骨窗微创脑出血清除术，B组49例患者实施早期小骨窗微创脑出血清除术，C组51例患者实施超早期微创血肿清除术，比较三组疗效。结果：B、C两组组患者预后不良率分别为12.24%、15.68%，显著比A组5.26%高，差异有统计学意义（P<0.05）；B、C两组患者术后半个月、半年的GOS评分均比A组低，差别较大，P<0.05，有统计学意义。结论：对高血压脑出血患者进行治疗时，应用超早期小骨窗微创脑出血清除术具有良好的临床效果，能够有效改善患者的预后情况，值得推广应用。
Objective: To study the effect of minimally invasive intracerebral hemorrhage in the treatment of hypertensive intracerebral hemorrhage using ultra-small bone window. Methods: From April 2013 to April 2015 in our hospital for treatment of 157 patients with hypertensive intracerebral hemorrhage as the research object, divided into three groups, A group of 57 patients with minimally invasive brain ultra-early small window of brain hemorrhage, In group B, 49 patients underwent minimally invasive craniotomy with small trabecular meshwork, and 51 patients in group C underwent ultra-early minimally invasive hematoma resection. The curative effect was compared between the three groups. Results: The poor prognosis of patients in group B and C were 12.24% and 15.68%, respectively, which was significantly higher than that of group A (5.26%) (P <0.05) , Six months GOS scores were lower than the A group, the difference is larger, P & lt; 0.05, with statistical significance. Conclusion: The treatment of patients with hypertensive intracerebral hemorrhage, the application of ultra-early small bone window minimally invasive cerebral hemorrhage surgery has a good clinical effect, can effectively improve the prognosis of patients, it is worth promoting the application.